China · Research startup
China · Hangzhou DAC Biotech Co., Ltd.
Duoxi is a China-based biotechnology company that develops antibody-drug conjugates for the treatment of cancer.
Funding reportedLast round: Series C
What company datasets say Hangzhou DAC Biotech Co., Ltd. raised
Funding, as reported
Reported in all1.1Bin the source's currency
Rounds5
Last roundSeries C
Last round size156M
Last round dateMay 2021
Investors listed11
The company, in detail
What they build
Built with from their website
WOWApacheTencent QQ APIViewport MetaMobile FriendlyBootstrapjQueryjQuery UISwiperICP
+3 more
Animate.cssNginxAlibaba Cloud
- Sector
- Research
- Region
- Zhejiang
- Revenue
- 10M a year, as listed
- Full record
- Every detail in the company directory
Research in China
Startups like it
CMAB BiopharmaSuzhou · founded 2017Raised
HaploX BiotechnologyShenzhen Shi · founded 2014Raised
TriArm Therapeuticsfounded 2018Raised
Cure GeneticsSuzhou · founded 2016Raised
BGI GroupShenzhen Shi · founded 1999
Baiming Xinkang Biotechnology (Hangzhou) Co., Ltd. Worgpharma)Hang Zhou Shi · founded 2018
Abogen BiosciencesWuxi · founded 2019
Chengdu Qitan Technology Co., Ltd.Beijing · founded 2016
Is this your company?
Add your raise, your deck and your story, and put Hangzhou DAC Biotech Co., Ltd. in front of investors. Or tell us what we have wrong.